Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0 (APPOINT 2.0): A Multi-center Randomized Controlled Trial

NCT06488781 is registered in ClinicalTrials.gov with University of Oklahoma as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06488781 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antibiotic Prophylaxis to Prevent Obesity-Related Induction Complications in Nulliparae at Term 2.0 (APPOINT 2.0): A Multi-center Randomized Controlled Trial
Lead sponsor
University of Oklahoma
Phase
Phase 2
Overall status
Recruiting
Start date
April 29, 2025
Completion date
December 31, 2028
Enrollment
787 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

labor complication, obesity in pregnancy